Loading…
Sectoral / Thematic · ITI Mutual Fund · AMFI code 149268ITI Pharma and Healthcare Fund
Disclosed for 5 months, May 2026 to Sep 2026.
Portfolio value
₹266 Cr
down ₹10.2 Cr vs Aug 2026
- Stocks held
- 37
- unchanged
- Top 10 weight
- 57.0%
- of the portfolio in its ten largest
- Cash & debt
- 0.7%
- cash, money market and debt
- Moves this month
- 1 in · 1 out
- added to 9, trimmed 26
ITI Pharma and Healthcare Fund is an active equity fund in the Sectoral / Thematic category from ITI Mutual Fund. In September 2026 it disclosed 37 stocks worth ₹266 Cr, down ₹10.2 Cr from Aug 2026. Its largest positions were Sun Pharmaceutical Industries Limited (12.0%), Divi's Laboratories Limited (9.5%), Apollo Hospitals Enterprise Limited (5.4%); the ten largest together made up 57.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 75.3% of its equity. Cash and debt stood at 0.7%. Compared with Aug 2026 the fund entered 1 new stock and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
76%
Top-10 weight is higher than 76% of peers
Breadth
35%
Holds more stocks than 35% of peers
Cash
9%
Holds more cash than 9% of peers
What these mean: concentration · cash
Holdings in September 2026
Download CSVEvery line the fund disclosed, with the change against Aug 2026. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 11.96% | down 0.63 pts | ₹31.8 Cr | down ₹2.9 Cr | Trimmed |
| Divi's Laboratories Limited | 9.51% | up 0.28 pts | ₹25.3 Cr | down ₹20 L | Trimmed |
| Apollo Hospitals Enterprise Limited | 5.45% | down 0.27 pts | ₹14.5 Cr | down ₹1.3 Cr | Trimmed |
| Dr. Reddy's Laboratories Limited | 4.78% | up 0.47 pts | ₹12.7 Cr | up ₹81 L | Added |
| Torrent Pharmaceuticals Limited | 4.78% | up 0.02 pts | ₹12.7 Cr | down ₹42 L | Trimmed |
| Max Healthcare Institute Limited | 4.49% | down 0.36 pts | ₹11.9 Cr | down ₹1.4 Cr | Trimmed |
| Cipla Limited | 4.19% | down 0.04 pts | ₹11.1 Cr | down ₹52 L | Trimmed |
| Laurus Labs Limited | 4.02% | down <0.01 pts | ₹10.7 Cr | down ₹41 L | Trimmed |
| Aurobindo Pharma Limited | 4.01% | up 0.04 pts | ₹10.7 Cr | down ₹29 L | Trimmed |
| Mankind Pharma Limited | 3.78% | up 0.46 pts | ₹10.1 Cr | up ₹90 L | Added |
| Suven Pharmaceuticals Limited | 3.14% | up 0.03 pts | ₹8.3 Cr | down ₹22 L | Trimmed |
| Alkem Laboratories Limited | 3.09% | up 0.17 pts | ₹8.2 Cr | up ₹15 L | Added |
| Neuland Laboratories Limited | 3.07% | down 0.12 pts | ₹8.2 Cr | down ₹63 L | Trimmed |
| Global Health Limited | 2.85% | down 0.13 pts | ₹7.6 Cr | down ₹64 L | Trimmed |
| Fortis Healthcare Limited | 2.77% | down 0.05 pts | ₹7.4 Cr | down ₹43 L | Trimmed |
| Abbott India Limited | 2.14% | up 0.18 pts | ₹5.7 Cr | up ₹27 L | Added |
| Lupin Limited | 2.04% | down 0.39 pts | ₹5.4 Cr | down ₹1.3 Cr | Trimmed |
| IPCA Laboratories Limited | 1.94% | up 0.03 pts | ₹5.2 Cr | down ₹13 L | Trimmed |
| Sai Life Sciences Limited | 1.87% | up 0.27 pts | ₹5 Cr | up ₹57 L | Added |
| Shilpa Medicare Limited | 1.61% | up 0.02 pts | ₹4.3 Cr | down ₹10 L | Trimmed |
| Aster DM Healthcare Limited | 1.59% | up 0.13 pts | ₹4.2 Cr | up ₹20 L | Added |
| Poly Medicure Limited | 1.48% | down 0.02 pts | ₹3.9 Cr | down ₹20 L | Trimmed |
| Healthcare Global Enterprises Limited | 1.47% | down 0.09 pts | ₹3.9 Cr | down ₹39 L | Trimmed |
| Piramal Pharma Limited | 1.27% | down 0.05 pts | ₹3.4 Cr | down ₹26 L | Trimmed |
| Anthem Biosciences Limited | 1.25% | down <0.01 pts | ₹3.3 Cr | down ₹13 L | Trimmed |
| Shaily Engineering Plastics Limited | 1.22% | down 0.04 pts | ₹3.2 Cr | down ₹22 L | Trimmed |
| Glenmark Pharmaceuticals Limited | 1.13% | down 0.03 pts | ₹3 Cr | down ₹19 L | Trimmed |
| Gland Pharma Limited | 1.03% | up 1.03 pts | ₹2.7 Cr | up ₹2.7 Cr | New |
| Supriya Lifescience Limited | 1.00% | up 0.19 pts | ₹2.7 Cr | up ₹43 L | Added |
| Rainbow Childrens Medicare Limited | 1.00% | up 0.07 pts | ₹2.6 Cr | up ₹8 L | Added |
| GlaxoSmithKline Pharmaceuticals Limited | 0.96% | down 0.06 pts | ₹2.6 Cr | down ₹26 L | Trimmed |
| Linde India Limited | 0.92% | down 0.07 pts | ₹2.4 Cr | down ₹30 L | Trimmed |
| Biocon Limited | 0.81% | down 0.06 pts | ₹2.2 Cr | down ₹24 L | Trimmed |
| Zydus Lifesciences Limited | 0.73% | up 0.03 pts | ₹2 Cr | up ₹0 L | Held |
| Metropolis Healthcare Limited | 0.71% | down 0.03 pts | ₹1.9 Cr | down ₹14 L | Trimmed |
| Cash, TREPS & receivables | 0.71% | down <0.01 pts | ₹1.9 Cr | down ₹8 L | Trimmed |
| Caplin Point Laboratories Limited | 0.68% | up 0.07 pts | ₹1.8 Cr | up ₹13 L | Added |
| Syngene International Limited | 0.57% | down 0.03 pts | ₹1.5 Cr | down ₹15 L | Trimmed |
What changed, Aug 2026 to Sep 2026
New New positions (1)
- Gland Pharma Limited1.0% · ₹2.7 Cr
Exited Exited (1)
- Thyrocare Technologies Limitedwas 1.1% · ₹2.9 Cr
Added Biggest additions
- Mankind Pharma Limitedup ₹90 L (+0.46% pts)
- Dr. Reddy's Laboratories Limitedup ₹81 L (+0.47% pts)
- Sai Life Sciences Limitedup ₹57 L (+0.27% pts)
- Supriya Lifescience Limitedup ₹43 L (+0.19% pts)
- Abbott India Limitedup ₹27 L (+0.18% pts)
- Aster DM Healthcare Limitedup ₹20 L (+0.13% pts)
- Alkem Laboratories Limitedup ₹15 L (+0.17% pts)
- Caplin Point Laboratories Limitedup ₹13 L (+0.07% pts)
- Rainbow Childrens Medicare Limitedup ₹8 L (+0.07% pts)
Trimmed Biggest reductions
- Sun Pharmaceutical Industries Limiteddown ₹2.9 Cr (−0.63% pts)
- Max Healthcare Institute Limiteddown ₹1.4 Cr (−0.36% pts)
- Apollo Hospitals Enterprise Limiteddown ₹1.3 Cr (−0.27% pts)
- Lupin Limiteddown ₹1.3 Cr (−0.39% pts)
- Global Health Limiteddown ₹64 L (−0.13% pts)
- Neuland Laboratories Limiteddown ₹63 L (−0.12% pts)
- Cipla Limiteddown ₹52 L (−0.04% pts)
- Fortis Healthcare Limiteddown ₹43 L (−0.05% pts)
- Torrent Pharmaceuticals Limiteddown ₹42 L (+0.02% pts)
- Laurus Labs Limiteddown ₹41 L (−<0.01% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Aug 2026, the weight rose most in Pharmaceuticals & Biotechnology (+1.9 pts), and fell most in Healthcare Services (−1.8 pts).
- Pharmaceuticals & Biotechnology73.4% → 75.3%+1.9 pts
- Healthcare Services22.9% → 21.0%−1.8 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jun 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 72.8% | 73.4% | 75.3% |
| Healthcare Services | 21.3% | 22.9% | 21.0% |
| Healthcare Equipment & Supplies | 1.3% | 1.5% | 1.5% |
| Consumer Durables | 1.3% | 1.3% | 1.2% |
| Chemicals & Petrochemicals | 1.3% | 1.0% | 0.9% |
Allocation in Sep 2026change vs Aug 2026
- Pharmaceuticals & Biotechnology (25)75.3%▲ 1.9 pts
- Healthcare Services (9)21.0%▼ 1.8 pts
- Healthcare Equipment & Supplies (1)1.5%
- Consumer Durables (1)1.2%
- Chemicals & Petrochemicals (1)0.9%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Sep 2026
0.7%
unchanged vs Aug 2026
- Cash alone
- 0.7%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 0.7% – 3.3%
- lowest to highest · record 3.3% in Jun 2026
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.